Renaissance Capital logo

P3 Health Partners (Foresight Acquisition) Priced, Nasdaq: PIII

Blank check company targeting consumer tech and healthcare industries (completed 12/3/2021).

Industry: SPAC

Latest Trade: $0.45 0.00 (0.0%)

First Day Return: +3.0%

Return from IPO: -95.5%

Industry: SPAC

We are a newly organized, blank check company incorporated as a Delaware corporation and formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. We have not selected any specific target business and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any target business regarding a business combination with our company. While we may pursue an initial business combination with a business in any industry, sector or stage of its corporate evolution, we initially intend to capitalize on the track record and experience of our management team and sponsor and focus our search in the technology-enabled consumer and consumer healthcare industries. We believe our team is uniquely positioned and will have proprietary deal flow in these sectors given our collective successful track record as operators, investors and entrepreneurs, and our principals’ track record of success initiating transformative mergers and acquisitions, operational acumen and strong network in these sectors.
more less
IPO Data
IPO File Date 01/08/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 27.5
Deal Size ($mm) $275
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 02/09/2021
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 27.5
Deal Size ($mm) $275
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
TD Cowen
Company Data
Headquarters Chicago, IL, United States
Founded 2020
Employees 2
Website www.foresightacq.com

P3 Health Partners (Foresight Acquisition) (PIII) Performance